Delhi HC restrains generic pharma firms from making, selling patent drug of Novartis

The plea said the plaintiff through a press release of January 28, 2019 issued by the defendant came to know about its act in launching a pharmaceutical composition comprising of the patented combination of Sacubitril and Valsartan tablet under the brand VALSAC as a combination drug.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news